Background MM-II, a novel suspension of empty large multilamellar liposomes composed of dimyristoylphosphatidylcholine (DMPC) and dipalmitoylphosphatidylcholine (DPPC), has demonstrated beneficial ...

Objectives We investigated whether local joint swelling recurs in the same joints over time in patients with rheumatoid arthritis (RA) who are treated to target. Methods Patients with newly diagnosed ...

Correspondence to Professor Christopher J Edwards, Musculoskeletal Research Unit, NIHR Southampton Clinical Rsearch Facility, University Hospital Southampton, Southampton, UK; cedwards{at}soton.ac.uk ...

Background There is emerging evidence that the development and progression of osteoarthritis (OA) is associated with inflammation. C reactive protein (CRP), a systemic marker for inflammation, may be ...

Department of Rheumatology, St. Vincent's University Hospital, Dublin 4, Ireland Dr E Murphy, Department of Rheumatology, Education and Research Centre, St Vincent's Hospital, Elm Park, Dublin 4, ...

1 Academic Rheumatology, University of Nottingham, Clinical Sciences Building, City Hospital, Nottingham NG5 1PB, UK 2 Rheumatology Unit, Nottingham City Hospital, Nottingham NG5 1PB, UK ...

Dr G Peat, Primary Care Sciences Research Centre, School of Postgraduate Medicine, Keele University, The Medical Institute, Hartshill Road, Stoke-on-Trent ST7 4NY, UKg.m.peat{at}hfac.keele.ac.uk ...

1 Institute for Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria Departments of Immunology and Medical Biophysics, University of Toronto, University Health Network, Canada ...

The first choice for prevention of corticosteroid osteoporosis is a potent oral bisphosphonate—for example, alendronate or risedronate. Intravenous bisphosphonates should be considered for patients ...

Research Laboratory and Academic Unit of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genova, Italy Dr M Cutolo, Research Laboratory and Academic Unit of Clinical ...

1 Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC, USA 2 Department of Dermatology, University of Utah Health Sciences Center, Salt Lake City, UT, USA ...

Objectives To assess as primary objective, the efficacy of anakinra in patients with KD who fail to respond to at least one infusion of 2g/kg of IVIg. To assess its safety and tolerability and its ...